Related Experiment Video
Updated: Mar 23, 2026
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis
Linnea Xuereb1, Pauline H Go, Babbaljeet Kaur
1From the *Wayne State University School of Medicine, Detroit, Michigan; †Division of Cardiothoracic Surgery, Henry Ford Hospital, Heart and Vascular Institute, Detroit, Michigan; and ‡Division of Cardiothoracic Transplant and Assist Devices, Texas Heart Institute, Baylor College of Medicine, Houston, Texas.
Abstract:
The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).
More Related Videos
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021